Gene · 990
Papers3,285
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
21 to 40 of 3,285
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| WDHD1 promotes hepatocellular carcinoma progression by affecting the cell cycle and immune evasion. | Transl Oncol | 2026 | 41850053 | PubTator, text mining | PubMed |
| USP1 promotes hepatocellular carcinoma progression by modulating mitophagy via stabilizing MCM3 to regulate the Keap1-Nrf2 axis. | iScience | 2026 | 41797940 | PubTator, text mining | PubMed |
| Sarcomatoid Renal Cell Carcinoma: Biological Features and Therapeutic Implications-A Narrative Review. | Curr Urol Rep | 2026 | 41792526 | PubTator, text mining | PubMed |
| RPL28 mediates sorafenib resistance in hepatocellular carcinoma by downregulating CDC6 expression. | Front Oncol | 2026 | 41777648 | PubTator, text mining | PubMed |
| Anti-thymocyte globulin-resistant CD4+ memory T cells contribute to haplo-fever after allogeneic hematopoietic stem cell transplantation. | Blood Sci | 2026 | 41768796 | PubTator, text mining | PubMed |
| Paired-Box (PAX) Gene Signatures as a Biomarker of Breast Cancer Progression. | Int J Mol Sci | 2026 | 41752124 | PubTator, text mining | PubMed |
| PRDM1 restricts bladder cancer progression and enhances chemosensitivity by suppressing OTUD6A-mediated deubiquitination of CDC6. | Cell Death Dis | 2026 | 41724787 | PubTator, text mining | PubMed |
| A Meier-Gorlin syndrome mutation impairs the loading of the MCM2-7 complex during DNA replication initiation. | Proc Natl Acad Sci U S A | 2026 | 41719335 | PubTator, text mining | PubMed |
| Tumor cell cycle regulation: integrated perspective of stage characteristics, regulatory networks, and signaling pathway intervention strategies. | Mol Biomed | 2026 | 41692895 | PubTator, text mining | PubMed |
| Study on biomarkers associated with epigenetic factors in endometriosis combining transcriptome with experimental validation. | PeerJ | 2026 | 41660070 | PubTator, text mining | PubMed |
| Identification and inhibition of the Cyclin D Rb-docking interface that drives cell division. | bioRxiv | 2026 | 41648226 | PubTator, text mining | PubMed |
| A non-canonical role for HIF-1α: redirecting DGCR8 to the RNA exosome for snoRNA degradation and translational modulation. | Nucleic Acids Res | 2026 | 41626696 | PubTator, text mining | PubMed |
| Separate transcription and splicing gene networks are linked and coordinated by the pRb-E2F pathway. | Nucleic Acids Res | 2026 | 41614303 | PubTator, text mining | PubMed |
| CDC6 promotes keratinocyte senescence through the CCND1/P53 signaling in ischemia-reperfusion injury-induced pressure injury. | Exp Cell Res | 2026 | 41580178 | PubTator, text mining | PubMed |
| Dysregulation of atrazine-associated core gene networks and risk prediction in human cancers: Insights from integrated transcriptomics and network toxicology analyses. | Ecotoxicol Environ Saf | 2026 | 41512780 | PubTator, text mining | PubMed |
| PQQ Modulates Cell Cycle and DNA Replication Programs to Alleviate Replicative Senescence in Human Umbilical Cord Mesenchymal Stromal Cells. | Stem Cell Rev Rep | 2026 | 41483450 | PubTator, text mining | PubMed |
| Molecular impacts of Meier-Gorlin syndrome mutations on human origin licensing. | J Biol Chem | 2026 | 41448435 | PubTator, text mining | PubMed |
| A YAP/TAZ-CDC6 Axis Initiates and Maintains Malignant Transformation. | Cancer Sci | 2026 | 41316737 | PubTator, text mining | PubMed |
| Synergistic Efficacy of Gedatolisib and Darolutamide in Prostate Cancer to Overcome Resistance to Androgen-Targeted Therapy. | Int J Mol Sci | 2025 | 41778397 | PubTator, text mining | PubMed |
| Geminin inhibits DNA replication licensing by sterically blocking CDT1-MCM2 interactions. | Nat Commun | 2025 | 41365879 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/990/papers?page=2